What's Covered in this Webinar?
This webinar recording provides a regulatory perspective on what is expected from an independent and objective assessment of clinical data.
Discussion points include;
- What the FDA and EMA are encouraging Sponsors to look at as part of their assessment of data quality.
- Identifying the different types of data analysis required to de-risk studies
- A review of case studies that exemplify a powerful approach to data management
Got a question? Give us a call on 0032 10 77 89 10, or send us an email to firstname.lastname@example.org